Cambridge Cognition Holdings PLC (LON:COG) had its Corporate rating reiterated by FinnCap

Analyst Ratings For Cambridge Cognition Holdings PLC (LON:COG)

Story continues below

Today, FinnCap reiterated its Corporate rating on Cambridge Cognition Holdings PLC (LON:COG).

There are 0 Strong Buy Ratings, no Sell Ratings, no Hold Ratings, no Buy Ratings on the stock.

The current consensus rating on Cambridge Cognition Holdings PLC (LON:COG) is N/A with a consensus target price of GBX 175 per share, a potential .

Some recent analyst ratings include

  • 3/7/2019-Cambridge Cognition Holdings PLC (LON:COG) had its Corporate rating reiterated by FinnCap
  • 3/31/2017-Cambridge Cognition Holdings PLC (LON:COG) has coverage initiated with a Buy rating

    About Cambridge Cognition Holdings PLC (LON:COG)
    Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health products. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from phases I–IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and Cognitive health and wellbeing, which Optimize mental wellbeing and performance throughout the life. The company was incorporated in 2012 and is based in Cambridge, the United Kingdom.

    Recent Trading Activity for Cambridge Cognition Holdings PLC (LON:COG)
    Shares of Cambridge Cognition Holdings PLC closed the previous trading session at 76,35 −6,15 7,45 % with 25.72 shares trading hands.

    An ad to help with our costs